Yorkshire & North East

Regional office hubs primed for £600m sale
Canadian investor and joint venture partner have lined up mammoth disposal
Latest Articles

Leeds office to become cancer care centre
27,000 sq ft office will become oncology and haematology treatment facility

Avison Young names Leeds managing director
James Pitt promoted to succeed Stuart Howie, who becomes principal and devolution delivery lead

Keyland puts West Yorkshire industrial site up for sale
DHP has been instructed to sell the phase two of Interchange 26 in Bradford

KKR completes £230m UK student accommodation portfolio purchase
Collection of 2,179 student beds offloaded by Curlew Student Trust II
-
-
Life sciences
Merck scraps £1bn London research hub plans
-
Hotels & Leisure
LondonMetric completes on £79m of triple net lease acquisitions
-
Opinion
Why Chinese e-commerce giants are turning to Europe
-
People
German manufacturer Schaeffler hires former Colliers broker
-
Residential
Q+A: Colliers’ Alanna Peach – “Residential is a frustrating place at present”
-
Office
Regional office hubs primed for £600m sale
-
Retail
Another day in property paradise: Phil Collins buys Edinburgh block
-
Student Accommodation
GSA urges government action as Ireland faces 68,000 student bed shortfall
-
Logistics
Ask plots 115,000 sq ft logistics scheme at Manchester Business Park
-
Opinion
Life sciences is making a comeback – investors should watch closely
-
Corporate
Hammerson lines up new chief executive
-
London
Nuveen lines up new buyer for £340m Can of Ham
-
Corporate
AustralianSuper recruits Canadian star as new European chief
-
Residential
Greystar snaps up £170m east London build-to-rent community
-
Corporate
Private equity firm circles PRS REIT
-
People
Schroders fund manager to depart
-
Ireland
Prime Dublin build-to-rent asset prepared for €180m+ sale
-
Hotels & Leisure
GIC teams up with hotels guru
-
Retail
Nuveen buys Stratford-upon-Avon park in out-of-town return
-
Corporate
Apollo joins forces with debt master for multi-billion mid-market lending push
-
Life sciences